Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

QTTB US Equity

Q32 Bio Inc.Health Care · Pharmaceutical Preparations · CIK 1661998 · FY ends Dec 31
$15.84
+0.55 (+3.60%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 1 13D · 5 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Point72 Asset Management, L.P.sec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Sirenia Capital Management LPsec.gov ↗
2026-08-058-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-3113G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Opaleye Management Inc.sec.gov ↗
2026-07-2113D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by ORBIMED ADVISORS LLCsec.gov ↗
2026-07-158-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-138-K 8.01Other eventssec.gov ↗
2026-07-138-K 8.01Other eventssec.gov ↗
2026-07-138-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-1013GSchedule 13G filed — ≥5% beneficial owner (passive) · by Boxer Capital Management, LLCsec.gov ↗
2026-07-0613G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Carlyle Group Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-06

Every row is a filed document, checked against its EDGAR index.